908 Devices (MASS) EBIT Growth (1y) (2021 - 2026)
908 Devices (MASS) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | 20.97% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | -18.12% |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 90.95% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 74.18% |
| 10 | 908 Devices | 260.68 Mn | 148.93 Mn | 6.88 Mn | -16.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.85% |
| Dec 31, 2025 | 118.46% |
| Sep 30, 2025 | 33.36% |
| Jun 30, 2025 | -77.55% |
| Mar 31, 2025 | -44.87% |
| Dec 31, 2024 | -72.44% |
| Sep 30, 2024 | -169.49% |
| Jun 30, 2024 | 21.94% |
| Mar 31, 2024 | 41.53% |
| Dec 31, 2023 | 6.05% |
| Sep 30, 2023 | -27.05% |
| Jun 30, 2023 | -30.71% |
| Mar 31, 2023 | -36.72% |
| Dec 31, 2022 | -193.03% |
| Sep 30, 2022 | -35.60% |
| Jun 30, 2022 | -12.26% |
| Mar 31, 2022 | -63.87% |
| Dec 31, 2021 | 9.21% |
| Sep 30, 2021 | -308.04% |
| Jun 30, 2021 | -450.33% |